Canada
· Delayed Price · Currency is CAD Andlauer Healthcare Group Statistics
Total Valuation
Andlauer Healthcare Group has a market cap or net worth of CAD 1.68 billion. The enterprise value is 1.80 billion.
| Market Cap | 1.68B |
| Enterprise Value | 1.80B |
Important Dates
The last earnings date was Wednesday, November 6, 2024.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | Sep 27, 2024 |
Share Statistics
Andlauer Healthcare Group has 39.29 million shares outstanding. The number of shares has decreased by -2.83% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 39.29M |
| Shares Change (YoY) | -2.83% |
| Shares Change (QoQ) | -4.31% |
| Owned by Insiders (%) | 1.05% |
| Owned by Institutions (%) | 30.93% |
| Float | 17.97M |
Valuation Ratios
The trailing PE ratio is 27.04 and the forward PE ratio is 24.82.
| PE Ratio | 27.04 |
| Forward PE | 24.82 |
| PS Ratio | 2.68 |
| PB Ratio | 4.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.92 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.68, with an EV/FCF ratio of 17.08.
| EV / Earnings | 27.53 |
| EV / Sales | 2.77 |
| EV / EBITDA | 12.68 |
| EV / EBIT | 18.93 |
| EV / FCF | 17.08 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.39.
| Current Ratio | 1.44 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 1.12 |
| Debt / FCF | 1.51 |
| Interest Coverage | 11.98 |
Financial Efficiency
Return on equity (ROE) is 14.91% and return on invested capital (ROIC) is 10.21%.
| Return on Equity (ROE) | 14.91% |
| Return on Assets (ROA) | 8.83% |
| Return on Capital (ROIC) | 10.21% |
| Revenue Per Employee | 284,389 |
| Profits Per Employee | 28,603 |
| Employee Count | 2,290 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 91.78 |
Taxes
In the past 12 months, Andlauer Healthcare Group has paid 24.07 million in taxes.
| Income Tax | 24.07M |
| Effective Tax Rate | 27.16% |
Stock Price Statistics
The stock price has increased by +11.21% in the last 52 weeks. The beta is 0.66, so Andlauer Healthcare Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +11.21% |
| 50-Day Moving Average | 40.22 |
| 200-Day Moving Average | 40.22 |
| Relative Strength Index (RSI) | 58.33 |
| Average Volume (20 Days) | 22,329 |
Short Selling Information
The latest short interest is 169,318, so 0.91% of the outstanding shares have been sold short.
| Short Interest | 169,318 |
| Short Previous Month | 126,152 |
| Short % of Shares Out | 0.91% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Andlauer Healthcare Group had revenue of CAD 651.25 million and earned 65.50 million in profits. Earnings per share was 1.58.
| Revenue | 651.25M |
| Gross Profit | 219.21M |
| Operating Income | 95.27M |
| Pretax Income | 89.84M |
| Net Income | 65.50M |
| EBITDA | 110.66M |
| EBIT | 95.27M |
| Earnings Per Share (EPS) | 1.58 |
Balance Sheet
The company has 35.99 million in cash and 158.97 million in debt, giving a net cash position of -122.98 million or -3.13 per share.
| Cash & Cash Equivalents | 35.99M |
| Total Debt | 158.97M |
| Net Cash | -122.98M |
| Net Cash Per Share | -3.13 |
| Equity (Book Value) | 404.42M |
| Book Value Per Share | 10.29 |
| Working Capital | 47.03M |
Cash Flow
In the last 12 months, operating cash flow was 126.94 million and capital expenditures -21.38 million, giving a free cash flow of 105.57 million.
| Operating Cash Flow | 126.94M |
| Capital Expenditures | -21.38M |
| Free Cash Flow | 105.57M |
| FCF Per Share | 2.69 |
Margins
Gross margin is 33.66%, with operating and profit margins of 14.63% and 10.06%.
| Gross Margin | 33.66% |
| Operating Margin | 14.63% |
| Pretax Margin | 13.80% |
| Profit Margin | 10.06% |
| EBITDA Margin | 16.99% |
| EBIT Margin | 14.63% |
| FCF Margin | 16.21% |
Dividends & Yields
This stock pays an annual dividend of 0.44, which amounts to a dividend yield of 1.03%.
| Dividend Per Share | 0.44 |
| Dividend Yield | 1.03% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 24.64% |
| Buyback Yield | 2.83% |
| Shareholder Yield | 3.85% |
| Earnings Yield | 3.70% |
| FCF Yield | 6.28% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Andlauer Healthcare Group has an Altman Z-Score of 5.98 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.98 |
| Piotroski F-Score | 6 |